Healthcare

RPG Life Sciences has launched Naprosyn ES, a groundbreaking combination of Naproxen and Esomeprazole, addressing a pressing need for patients on long-term NSAID therapy who face an elevated risk of gastrointestinal complications. This innovative product is poised to revolutionize the way patients manage chronic conditions, offering a safer and more effective treatment option.